Shanghai Bingmei Medical Technology Co., Ltd. started its project in December 2011, and took nine years to develop and design a hydrogen inhalation medical device - a hydrogen-oxygen atomizer. It uses hydrogen inhalation combined with drug atomization to develop a new gas-driven atomization delivery. Way. Through the development of multiple patented technologies, 192 international invention, design and utility model patents have been approved (updated to August 2020).

The company submitted an application for classification of medical devices in July 2014. In March 2015, it was defined as Class III medical devices by the State Food and Drug Administration, with a classification code of 6823, and passed the Shanghai Medical Device Testing Institute in August 2015. safe type detection.

On February 2, 2020, he obtained the Medical Device Registration Certificate of the People's Republic of China (National Equipment Registration 20203080066).

Bingmei is committed to the continuous development of the hydrogen industry and fully supports the research of hydrogen molecular medicine. It hopes to apply this simple intervention and measures to the fields of disease assisted treatment, elderly care, rehabilitation and sub-health.